The synthesis and characterization of Ag

Synthesis of 3', 6'-bis (diethylamino)-2-(2-hydroxyethyl)-3', 9'-dihydrospiro [isoindoline-1, 9'-xanthen]-
3-one (1).
Typically, 2-aminoethanol (252 μL, 4.16 mmol) was added to a solution of Rhodamine B (0.500 g, 1.04 mmol) in ethanol (40 mL), and the resulting mixture was heated at 120 °C for 2 days. The reaction mixture was cooled to room temperature and the solvent was evaporated under vacuo. The residue obtained was dissolved in EtOAc (30 mL) and successively washed with water (20 mL) and brine (10 mL), dried over Na2SO4 and evaporated under vacuo. Finally, the solid obtained was purified by silica gel chromatography (10 % MeOH in CH2Cl2) to get compound 1 as a white solid. 1 H NMR (400 MHz, CDCl3) δ = 7.95 -7.82 (m, 1H), 7.44 (dt, J = 7.3, 3.7 Hz, 2H), 7.15 -6.98 (m, 1H), 6.49 (d, J = 8.8 Hz, 2H), 6.38 (d, J = 2.5 Hz, 2H), 6.29 (dd, J = 8.9, 2.6 Hz, 2H), 4.21 (t, J = 5.5 Hz, 1H), 3.47 (dd, J = 9.6, 4.9 Hz, 2H), 3.39 -3.22 (m, 10H),
1.16 (t, J = 7.1 Hz, 12H). 13 C NMR (101 MHz, CDCl3) δ = 170. 10, 153.91, 153.27, 148.88, 132.71, 130.43, 128.51, 128.15, 123.81, 122.90, 108.22, 104.75, 97.77, 65.88, 62.66, 44.63, 44.37, 12.60 (s 84, 151.58, 151.21, 146.91, 130.70, 128.60, 126.73, 126.12, 121.82, 120.97, 106.18, 103.23, 95.82, 62.70, 42.38, 41.09, 10.63 2. The characterization of silver nanoparticles (AgNPs) Figure S2 . UV-Vis spectrum (a) and TEM image (b) of the synthesized silver nanoparticles with a diameter about 60 nm.
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The characterization of immuno-complexes Ab1-MBs@AG@Ab2-AgNPs
The conjugation of labeled antibody Ab2 on the surface of silver nanoparticles AgNPs was evaluated by immunofluorescence experiments. Typically, 50 μL of Ab2-AgNPs blocked with BSA was first transferred into a 0.5-mL Eppendorf tube, and then 100 μL of 10 -6 g mL -1 Cy5-labeled second antibody solution were added, the mixture was incubated for 30 min at 37 °C with gentle mixing in a TS-100 ThermoShaker. The solution was repeatedly centrifuged under optimized conditions to get rid of the excess Cy5-labelled second antibody. The obtained Ab2-AgNPs modified with Cy5-labelled second antibody was re-dispersed into 100µL PBS (50 mM, pH 7.4) and its fluorescence was measured by fluorescence microscope. A similar experiment was also performed using BSA blocked AgNPs without Ab2 on the surface of AgNPs. As shown in Figure Immunofluorescence experiments were also used to evaluate the conjugation of antibody Ab1 on the surface of MBs. Typically, 50 μL of Ab1-MBs blocked with BSA was first transferred into a 0.5-mL
Eppendorf tube, and 100 μL of 10 -6 g mL -1 Cy5-labelled second antibody solution were added, the mixture S5 was incubated for 30 min at 37 °C with gentle mixing in a TS-100 ThermoShaker. After washing three times with phosphate buffer solution (50 mm, pH 7.4) including 0.05 % (v/v) Tween 20 (PBST), the Ab1-MBs was re-dispersed into 100 µL PBS (50 mM, pH 7.4) and its fluorescence was measured by fluorescence microscope. A similar experiment was also performed using BSA blocked MBs without Ab1. As shown in Figure S4 , for BSA blocked MBs, almost no fluorescence emission was observed at 664 nm. While the fluorescence intensity obviously enhanced for Ab1-MBs blocked with BSA. These results demonstrate the successful binding of Ab1 on the surface of MBs. Figure S4 . Fluorescence spectra of BSA blocked MBs (black line) and Ab1-MBs (red line) after incubating with Cy5 labelled second antibodies solution (10 -6 g mL -1 ) (ex: 646 nm; em: 664 nm).
In addition, in order to characterize the formation of immuno-complexes Ab1-MBs@AG@Ab2-AgNPs, the TEM images of single magnetic beads (analytes captured) Ab1-MBs@AG before and after binding
Ab2-AgNPs have been demonstrated. As shown in Figure S5 , there was no AgNPs could be observed for Ab1-MBs@AG before bound with Ab2-AgNPs ( Figure S5A ). However, it was clearly seen that AgNPs were combined on the surface of MBs ( Figure S5B 
The amount of antibody adsorbed to silver nanoparticles
The concentration of antibody was optimized to better combine with silver nanoparticles in AFP detection.
An AFP concentration of 10 ng mL -1 was used to the experiment. As depicted in Figure S5 , the concentration of antibody should be five times higher than that of AgNPs. Therefore, in the following experiment, a concentration of antibody that of ten times AgNPs was used to do the combination. 
Determination of detection limit
The limit of detection (LOD) of Ag + -FP for Ag + and the detection system for antigen were determined from the following equation:
Where σ is the standard deviation of the blank measurement; k is the slope between the fluorescence intensity versus analyte concentration. 
From the graph of AFP detection, we could get kAFP = 1.449 from equation (S3), and σAFP = 0.0358 from blank measurement. Thus the LOD of AFP could be calculated to be 70 pg·mL −1 . 488 are used to label the antibodies. With these techniques, the limit of detection is reduced to 0.14 ng mL -1 .
[S9] By utilizing amino-modified Mn-doped ZnS quantum dots (QDs) as solid supports, a direct fluorescent immunoassay is developed based on a fluorescent molecularly imprinted polymer (MIP), which is generated fluorescent turn-on by recognition with tumor biomarker. Thus, this detection method could allow the detection limit of CEA down to 0.04 ng mL -1 . The detection limits resulting from our method for AFP and C-reactive protein (CRP) are found to be 70 pg mL −1 and 30 pg mL −1 , respectively. Therefore, compared to these reported fluorescent immunoassay methods, our method shows higher sensitivity and lower fluorescence background. 
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